The IBN SINA Pharmaceutical Industry (DHA:IBNSINA) Total Inventories : BDT0.00 Mil (As of . 20)

View and export this data going back to . Start your Free Trial

What is The IBN SINA Pharmaceutical Industry Total Inventories?

The IBN SINA Pharmaceutical Industry's total inventories for the quarter that ended in . 20 was BDT0.00 Mil. The IBN SINA Pharmaceutical Industry's average total inventories from the quarter that ended in . 20 to the quarter that ended in . 20 was BDT0.00 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. The IBN SINA Pharmaceutical Industry's Net-Net Working Capital per share for the quarter that ended in . 20 was BDTN/A.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

The IBN SINA Pharmaceutical Industry Total Inventories Historical Data

The historical data trend for The IBN SINA Pharmaceutical Industry's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

The IBN SINA Pharmaceutical Industry Total Inventories Chart

The IBN SINA Pharmaceutical Industry Annual Data

Trend

Total Inventories

The IBN SINA Pharmaceutical Industry Semi-Annual Data

Total Inventories

The IBN SINA Pharmaceutical Industry Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.

The IBN SINA Pharmaceutical Industry (DHA:IBNSINA) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

The IBN SINA Pharmaceutical Industry's Net-Net Working Capital Per Share for the quarter that ended in . 20 is

	Net-Net Working Capital Per Share (Q: . 20 )
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(	+	0.75 *	+	0.5 *	-	N/A
-		-	)	/	0
=	N/A

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

The IBN SINA Pharmaceutical Industry's Days Inventory for the six months ended in . 20 is calculated as:

Days Inventory	=	Average Total Inventories (Q: . 20 )	/	Cost of Goods Sold (Q: . 20 )	*	Days in Period
	=	0	/		*	365 / 2
	=

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

The IBN SINA Pharmaceutical Industry's Inventory Turnover for the quarter that ended in . 20 is calculated as

Inventory Turnover	=	Cost of Goods Sold (Q: . 20 )	/	Average Total Inventories (Q: . 20 )
	=		/	0
	=	N/A

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

The IBN SINA Pharmaceutical Industry's Inventory to Revenue for the quarter that ended in . 20 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: . 20 )	/	Revenue (Q: . 20 )
	=	0	/
	=

Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.

The IBN SINA Pharmaceutical Industry Total Inventories Related Terms

Thank you for viewing the detailed overview of The IBN SINA Pharmaceutical Industry's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.

The IBN SINA Pharmaceutical Industry Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » The IBN SINA Pharmaceutical Industry PLC (DHA:IBNSINA) » Definitions » Total Inventories

Traded in Other Exchanges

N/A

Address

Mirpur Road, Tanin Center, 3 Asad Gate, Mohammadpur, Dhaka, BGD, 1207

Website

https://www.ibnsinapharma.com

The IBN SINA Pharmaceutical Industry PLC is engaged in the production and marketing of pharmaceutical drugs and natural medicines in both the local and international market.

The IBN SINA Pharmaceutical Industry Headlines

No Headlines